Cite
Efficacy of P2Y12 Receptor Blockers After Myocardial Infarction and Genetic Variability of their Metabolic Pathways.
MLA
Máchal, Jan, and Ota Hlinomaz. “Efficacy of P2Y12 Receptor Blockers After Myocardial Infarction and Genetic Variability of Their Metabolic Pathways.” Current Vascular Pharmacology, vol. 17, no. 1, 2019, pp. 35–40. EBSCOhost, https://doi.org/10.2174/1570161116666180206110657.
APA
Máchal, J., & Hlinomaz, O. (2019). Efficacy of P2Y12 Receptor Blockers After Myocardial Infarction and Genetic Variability of their Metabolic Pathways. Current Vascular Pharmacology, 17(1), 35–40. https://doi.org/10.2174/1570161116666180206110657
Chicago
Máchal, Jan, and Ota Hlinomaz. 2019. “Efficacy of P2Y12 Receptor Blockers After Myocardial Infarction and Genetic Variability of Their Metabolic Pathways.” Current Vascular Pharmacology 17 (1): 35–40. doi:10.2174/1570161116666180206110657.